Alfred D. Kingsley
Director at Lineage Cell Therapeutics; Director at Insight Molecular Diagnostics. Based in New York, New York.
- Rank
- 13802nd of 14,452
- Companies held
- 2
- Largest holding
- LCTX, 99.1% of total
- Latest SEC filing
- Jun 23, 2023
- Listed but not counted
- $309K
What the $5.4M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Lineage Cell Therapeutics LCTX Common Shares, no par value | Directly | 5,430,545 | $0.82 | $4.5M | 83.1% | Form 5, Dec 1, 2022 |
| Lineage Cell Therapeutics LCTX Common Shares, no par value | Through Corporation | 1,043,346 | $0.82 | $856K | 16.0% | Form 5, Dec 31, 2022 |
| Insight Molecular Diagnostics IMDX Common Stock, no par value | Directly | 24,456 split-adjusted | $1.66 | $41K | 0.8% | Form 4, Jun 23, 2023 |
| Insight Molecular Diagnostics IMDX Common Stock, no par value | Indirectly (see filing footnote) | 3,767 split-adjusted | $1.66 | $6K | 0.1% | Form 4, Jun 23, 2023 |
Share counts are the amounts Alfred D. Kingsley reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Alfred D. Kingsley's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Lineage Cell Therapeutics LCTX Common Shares, no par value | Through LP Held by a company or fund the insider manages | 375,351 | $0.82 | $308K | — | Form 5, Dec 31, 2022 |
| Insight Molecular Diagnostics IMDX Common Stock, no par value | Through Greenway Partners, LP Held by a company or fund the insider manages | 938 split-adjusted | $1.66 | $2K | — | Form 4, Jun 23, 2023 |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 13799 | John Washburn Chief Operating Officer, Sunbelt Rentals Holdings. Fort Mill, SC | $5.4M |
| 13800 | Brian M. Leary EVP & COO, Highwoods Properties. Raleigh, NC | $5.4M |
| 13801 | Thomas F. Kelly Director, Fabrinet. Dublin, CA | $5.4M |
| 13802 | Alfred D. Kingsley Director, Lineage Cell Therapeutics. New York, NY | $5.4M |
| 13803 | Jahmy J. Hindman Sr VP & Chief Technology Offcr, Deere &. Moline, IL | $5.4M |
| 13804 | Melanie J. Tinto SVP & Chief HR Officer, W.W. Grainger. Lake Forest, IL | $5.4M |
| 13805 | Tov Matitiahu S. Shem Chief Executive Officer, Clarivate | $5.4M |
Questions
How much stock does Alfred D. Kingsley own?
Alfred D. Kingsley holds $5,355,440 in listed stock based on SEC filings and current prices, mostly Lineage Cell Therapeutics (LCTX). That ranks 13802nd on the Stock Rich List.
Is this Alfred D. Kingsley's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.